Skip to main content
letter
. 2021 Dec 20;5(24):5584–5587. doi: 10.1182/bloodadvances.2021005974

Figure 2.

Figure 2.

Associations and outcome according to RDW levels at AML diagnosis in the validation set (n = 392). (A) Association with disease origin. OS (B) and EFS (C) applying a 20.7% cut-point (high vs low). sAML, secondary AML; tAML, treatment-related AML.